Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial

Details 詳細情報について

• CRID

  1360861710916529024

• DOI

  10.1016/s1473-3099(21)00396-0

• ISSN

  14733099

• Web Site

  https://api.elsevier.com/content/article/PII:S1473309921003960?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1473309921003960?httpAccept=text/plain

• Data Source

  • Crossref